Dosage of Tecartus

The usage and dosage of Tecartus (Tecartus) are determined based on the patient's specific condition and the doctor's prescription, as it is an individualized treatment. The following are general usage and dosage guidelines, but patients must follow their doctor's specific recommendations:

1. Usage:

TecartusTreatment needs to be carried out in a specially equipped medical facility to ensure that possible serious side effects can be managed during treatment.

Tecartus collects the patient's T cells and transforms them to attack CD19positive B -ALLCAR-T cells (Chimeric Antigen ReceptorT cells), and then reinjected into the patient for individualized treatment. This process is usually divided into the following steps:

a. Tcell collection: Doctors will collect T cells from the patient’s body.

b. Tcell modification: The collected T cells will be modified in the laboratory so that they express specific CD19-receptors, allowing them to attack leukemia cells.

c. TecartusTreatment: The modified T cells will be reinjected into the patient's body to become a one-time treatment.

2. Dosage:

The dosage of Tecartus varies based on the patient's weight and specific condition. Doctors will determine the appropriate dosage based on the patient's individual needs.

Typically, Tecartus treatment is usually a one-time treatment because the modified T cells can continue to work in the body. Therefore, patients usually only need one treatment with Tecartus.

Patients must strictly follow the doctor's advice and treatment plan to ensure the best treatment effect, and receive regular monitoring and follow-up from the doctor. In addition, Tecartus treatment may be associated with a range of side effects, so patients need to pay close attention to any discomfort or symptoms and manage them as recommended by their doctor. Treatment requires monitoring in a medical facility and, if necessary, measures to control side effects.

In summary, Tecartus (Tecartus) is a revolutionary, personalized treatment for B cell acute lymphoblastic leukemia (B-ALL). Patients must receive treatment under the guidance of a doctor and strictly adhere to the treatment plan to ensure optimal therapeutic effects and reduce the risk of side effects. This treatment represents a new avenue of treatment and offers hope for patients who have faced relapsed and refractory B-ALL.